Veterinary Medicines

SOLUZIONE ELETTROLITICA REIDRATANTE III

Authorised
  • Sodium chloride
  • Potassium chloride
  • Magnesium chloride hexahydrate
  • Calcium chloride dihydrate
  • Sodium acetate
  • Sodium citrate dihydrate
Download as PDF

Product identification

Medicine name:
SOLUZIONE ELETTROLITICA REIDRATANTE III
Active substance:
  • Sodium chloride
  • Potassium chloride
  • Magnesium chloride hexahydrate
  • Calcium chloride dihydrate
  • Sodium acetate
  • Sodium citrate dihydrate
Target species:
  • Cattle
  • Dog
  • Sheep
  • Horse (non food-producing)
  • Cat
  • Pig
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium chloride
    5.00
    gram(s)
    /
    1000.00
    millilitre(s)
  • Potassium chloride
    0.75
    gram(s)
    /
    1000.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    0.31
    gram(s)
    /
    1000.00
    millilitre(s)
  • Calcium chloride dihydrate
    0.35
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium acetate
    6.40
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium citrate dihydrate
    0.75
    gram(s)
    /
    1000.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse (non food-producing)
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Industria Farmaceutica Galenica Senese S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industria Farmaceutica Galenica Senese S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."